Svetlana Nikic, Founder of Precision Oncology Consulting, shared a post on LinkedIn:
“My favorite congress, ESMO25, is just around the corner.
As someone deeply involved in precision oncology and market access, I am especially drawn to sessions that highlight how innovation, equity, and patient impact intersect:
– ‘AI-based image biomarkers in oncology, radiology and pathology’
– ‘The future of health technology assessment (HTA) at the European level’
– ‘Digitalization and equality: Is there bias and discrimination in AI algorithms?’
– ‘Advancing cancer care through AI and real-world evidence: Opportunities and challenges for patient advocacy’
– ‘The next frontier of antibody-drug conjugate development’
These themes resonate strongly with my work and my passion for helping new technologies reach patients faster and more fairly. Looking forward to exchanging ideas and learning from colleagues and friends in Berlin later in October.
If you are developing novel cancer diagnostic tools, are a clinician with an exciting project in need of support, or a pharma colleague facing challenges with targeted therapy adoption due to biomarker testing gaps, let’s connect.
Use this link to block 30 min in my calender while at ESMO.”
More from Svetlana Nikic on OncoDaily.